Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for recovery quality after combined gastrointestinal endoscopy in older adults
ChiCTR2300071635Phase 4Recruiting
- Sponsor
- Beijing Hosipital
- Start
- Feb 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and fentanyl in None (2 arms), sponsored by Beijing Hosipital. Primary endpoint: Time of discharge. Started Feb 2023; status: recruiting.
02
Drugs
remimazolampropofolfentanyl
Beyond the preview
Go deeper on ChiCTR2300071635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071635.